Biotech and Healthcare Lead US IPO Wave as Tech Companies Remain on Sidelines ARKO Q1 2026 Earnings Adjusted Loss Narrows Sharply Beating Street Expectations by 57 Wall Street Analysts Share Mixed Perspectives on Legence Corp LGN